Tag: immunoglobulin E (IgE)

Aimmune + Xencor

Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development...

“In-licensing AIMab7195 demonstrates our commitment to enriching our pipeline and strengthening Aimmune’s global leadership in the evolving therapeutic landscape of food allergy treatments.”
Girl Drinking Milk

Children Allergic to Cow’s Milk Smaller and Lighter

Children allergic to cow’s milk are smaller and weigh less, according to the first published study to characterize growth trajectories from early childhood to adolescence in children with persistent food allergies.
Peanuts

Study: Antibody Injection Stops Peanut Allergy for 2 to 6 Weeks

A Stanford-led pilot study has provided early evidence that an antibody is a safe, effective and rapid food allergy treatment.
Omalizumab + OIT

Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple...

NIH and partners to assess whether Omalizumab can reduce allergic reactions.
Red Meat

Q&A: Everything You Need to Know About Alpha-gal Syndrome, the Meat...

What it is, what it does, how you catch it and how you prevent it.
Dr Pablo F Canete

New Cell Discovery Could Potentially Stop Allergies from Developing

The discovery could create a new approach for future allergy treatments.
Staphylococcus aureus

Common Skin Bacterium Puts Children with Severe Eczema at Higher Risk...

Young children with severe eczema infected with staphylococcus aureus run a higher risk of developing a food allergy.
Open Wide!

Study: Testing for Food Allergy by 'Brushing' Along the Gum Line

Could submitting to an allergy test in the future be as simple as opening your mouth and being brushed along the gum line?
Dr Kari Nadeau

Must Hear: Interview with Stanford Immunologist Dr Kari Nadeau – Defeating...

Dr Kari Nadeau, who runs the Sean Parker Center for Allergy and Asthma Research at Stanford University, takes us on a tour...
Bilgicer Lab

Researchers Develop First Functional Targeted Inhibitors of Peanut Allergens

“The success of this study is exciting because it opens the door to establishing an entirely new class of allergy therapeutics."